{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T03:44:27Z","timestamp":1789184667183,"version":"build-2803163510"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T00:00:00Z","timestamp":1742515200000},"content-version":"am","delay-in-days":293,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007161","name":"Boston University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007161","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AI59945"],"award-info":[{"award-number":["R01 AI59945"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 HL007035"],"award-info":[{"award-number":["T32 HL007035"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AI159945"],"award-info":[{"award-number":["R01 AI159945"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Microbiology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.mib.2024.102454","type":"journal-article","created":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T07:57:29Z","timestamp":1711007849000},"page":"102454","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Upping the ante: enhanced expression of interferon-antagonizing ORF6 and ORF9b proteins by SARS-CoV-2 variants of concern"],"prefix":"10.1016","volume":"79","author":[{"given":"Allen","family":"Caobi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8505-7054","authenticated-orcid":false,"given":"Mohsan","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mib.2024.102454_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvacx.2023.100377","article-title":"Disease severity of COVID-19 in different phases of the pandemic: do healthcare workers have better outcomes?","volume":"15","author":"Yang","year":"2023","journal-title":"Vaccin X"},{"key":"10.1016\/j.mib.2024.102454_bib2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ejim.2022.12.007","article-title":"Timeline analysis of clinical severity of COVID-19 in the general population","volume":"110","author":"Mattiuzzi","year":"2023","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.mib.2024.102454_bib3","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.mib.2024.102454_bib4","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.stem.2020.09.013","article-title":"SARS-CoV-2 infection of pluripotent stem cell-derived human lung alveolar type 2 cells elicits a rapid epithelial-intrinsic inflammatory response","volume":"27","author":"Huang","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.mib.2024.102454_bib5","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","article-title":"Imbalanced host response to SARS-CoV-2 drives development of COVID-19","volume":"181","author":"Blanco-Melo","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.mib.2024.102454_bib6","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine storm","volume":"383","author":"Fajgenbaum","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mib.2024.102454_bib7","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41586-020-2739-1","article-title":"The coding capacity of SARS-CoV-2","volume":"589","author":"Finkel","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.mib.2024.102454_sbref8","first-page":"178","article-title":"Innate immune evasion strategies of SARS-CoV-2","volume":"21","author":"Minkoff","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.mib.2024.102454_bib9","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/s41423-023-01104-y","article-title":"SARS-CoV-2 and innate immunity: the good, the bad, and the \"goldilocks\"","volume":"21","author":"Sievers","year":"2024","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.mib.2024.102454_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.940756","article-title":"Roles and functions of SARS-CoV-2 proteins in host immune evasion","volume":"13","author":"Rashid","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.mib.2024.102454_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24109072","article-title":"The mutational landscape of SARS-CoV-2","volume":"24","author":"Saldivar-Espinoza","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.mib.2024.102454_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1009147","article-title":"The interplay of SARS-CoV-2 evolution and constraints imposed by the structure and functionality of its proteins","volume":"17","author":"Jaroszewski","year":"2021","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.mib.2024.102454_bib13","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41579-023-00878-2","article-title":"The evolution of SARS-CoV-2","volume":"21","author":"Markov","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.mib.2024.102454_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104534","article-title":"SARS-CoV-2 variant transition dynamics are associated with vaccination rates, number of co-circulating variants, and convalescent immunity","volume":"91","author":"Beesley","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.mib.2024.102454_bib15","first-page":"162","article-title":"SARS-CoV-2 variant biology: immune escape, transmission and fitness","volume":"21","author":"Carabelli","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.mib.2024.102454_sbref16","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41586-021-04352-y","article-title":"Evolution of enhanced innate immune evasion by SARS-CoV-2","volume":"602","author":"Thorne","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.mib.2024.102454_sbref17","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2203760119","article-title":"Interferon resistance of emerging SARS-CoV-2 variants","volume":"119","author":"Guo","year":"2022","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.mib.2024.102454_bib18","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01604-22","article-title":"SARS-CoV-2 variant Delta potently suppresses innate immune response and evades interferon-activated antiviral responses in human colon epithelial cells","volume":"10","author":"Tandel","year":"2022","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.mib.2024.102454_bib19","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202201745","article-title":"Reduced replication but increased interferon resistance of SARS-CoV-2 Omicron BA.1","volume":"6","author":"Nchioua","year":"2023","journal-title":"Life Sci Alliance"},{"key":"10.1016\/j.mib.2024.102454_bib20","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00402-21","article-title":"Contribution of SARS-CoV-2 accessory proteins to viral pathogenicity in K18 human ACE2 transgenic mice","volume":"95","author":"Silvas","year":"2021","journal-title":"J Virol"},{"key":"10.1016\/j.mib.2024.102454_sbref21","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/j.chom.2023.08.003","article-title":"Impact of SARS-CoV-2 ORF6 and its variant polymorphisms on host responses and viral pathogenesis","volume":"31","author":"Kehrer","year":"2023","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.mib.2024.102454_bib22","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/emboj\/21.7.1754","article-title":"Regulated nuclear import of the STAT1 transcription factor by direct binding of importin-alpha","volume":"21","author":"McBride","year":"2002","journal-title":"EMBO J"},{"key":"10.1016\/j.mib.2024.102454_bib23","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jmb.2010.07.013","article-title":"Molecular basis for the recognition of phosphorylated STAT1 by importin alpha5","volume":"402","author":"Nardozzi","year":"2010","journal-title":"J Mol Biol"},{"key":"10.1016\/j.mib.2024.102454_bib24","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1038\/sj.jid.5700716","article-title":"Differential regulation of karyopherin alpha 2 expression by TGF-beta1 and IFN-gamma in normal human epidermal keratinocytes: evident contribution of KPNA2 for nuclear translocation of IRF-1","volume":"127","author":"Umegaki","year":"2007","journal-title":"J Investig Dermatol"},{"key":"10.1016\/j.mib.2024.102454_bib25","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.60821","article-title":"HIV-1 Vpr antagonizes innate immune activation by targeting karyopherin-mediated NF-kappaB\/IRF3 nuclear transport","volume":"9","author":"Khan","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.mib.2024.102454_bib26","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0959-440X(01)00264-0","article-title":"Karyopherins and nuclear import","volume":"11","author":"Chook","year":"2001","journal-title":"Curr Opin Struct Biol"},{"key":"10.1016\/j.mib.2024.102454_bib27","doi-asserted-by":"crossref","first-page":"7067","DOI":"10.1093\/emboj\/16.23.7067","article-title":"Extracellular signal-dependent nuclear import of Stat1 is mediated by nuclear pore-targeting complex formation with NPI-1, but not Rch1","volume":"16","author":"Sekimoto","year":"1997","journal-title":"EMBO J"},{"key":"10.1016\/j.mib.2024.102454_bib28","doi-asserted-by":"crossref","first-page":"28344","DOI":"10.1073\/pnas.2016650117","article-title":"SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling","volume":"117","author":"Miorin","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.mib.2024.102454_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-17665-9","article-title":"Activation and evasion of type I interferon responses by SARS-CoV-2","volume":"11","author":"Lei","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.mib.2024.102454_bib30","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41586-020-2286-9","article-title":"A SARS-CoV-2 protein interaction map reveals targets for drug repurposing","volume":"583","author":"Gordon","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.mib.2024.102454_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108234","article-title":"Evasion of type I interferon by SARS-CoV-2","volume":"33","author":"Xia","year":"2020","journal-title":"Cell Rep"},{"key":"10.1016\/j.mib.2024.102454_bib32","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00065-21","article-title":"SARS-CoV-2 ORF6 disrupts bidirectional nucleocytoplasmic transport through interactions with Rae1 and Nup98","volume":"12","author":"Addetia","year":"2021","journal-title":"mBio"},{"key":"10.1016\/j.mib.2024.102454_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108916","article-title":"Sarbecovirus ORF6 proteins hamper induction of interferon signaling","volume":"34","author":"Kimura","year":"2021","journal-title":"Cell Rep"},{"key":"10.1016\/j.mib.2024.102454_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/s42003-022-03427-4","article-title":"SARS-CoV-2 ORF6 disrupts nucleocytoplasmic trafficking to advance viral replication","volume":"5","author":"Miyamoto","year":"2022","journal-title":"Commun Biol"},{"key":"10.1016\/j.mib.2024.102454_sbref35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010349","article-title":"SARS-CoV-2 ORF6 disrupts innate immune signalling by inhibiting cellular mRNA export","volume":"18","author":"Hall","year":"2022","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.mib.2024.102454_bib36","article-title":"Structural basis for Sarbecovirus ORF6 mediated blockage of nucleocytoplasmic transport","volume":"13","author":"Gao","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.mib.2024.102454_bib37","article-title":"Molecular mechanism of SARS-CoVs Orf6 targeting the Rae1-Nup98 complex to compete with mRNA nuclear export","volume":"8","author":"Li","year":"2021","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.mib.2024.102454_bib38","doi-asserted-by":"crossref","DOI":"10.1038\/s42003-022-03565-9","article-title":"Altered subgenomic RNA abundance provides unique insight into SARS-CoV-2 B.1.1.7\/Alpha variant infections","volume":"5","author":"Parker","year":"2022","journal-title":"Commun Biol"},{"key":"10.1016\/j.mib.2024.102454_sbref39","doi-asserted-by":"crossref","first-page":"4597","DOI":"10.1016\/j.cell.2023.08.026","article-title":"SARS-CoV-2 variants evolve convergent strategies to remodel the host response","volume":"186","author":"Bouhaddou","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.mib.2024.102454_sbref40","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/s41564-023-01588-4","article-title":"Evolution of enhanced innate immune suppression by SARS-CoV-2 Omicron subvariants","volume":"9","author":"Reuschl","year":"2024","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.mib.2024.102454_bib41","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-17488-8","article-title":"SARS-CoV-2 proteome microarray for global profiling of COVID-19 specific IgG and IgM responses","volume":"11","author":"Jiang","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.mib.2024.102454_bib42","doi-asserted-by":"crossref","first-page":"3962","DOI":"10.1016\/j.cell.2021.05.046","article-title":"Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs","volume":"184","author":"Weingarten-Gabbay","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.mib.2024.102454_bib43","article-title":"The HLA-II immunopeptidome of SARS-CoV-2","volume":"43","author":"Weingarten-Gabbay","year":"2023","journal-title":"Cell Rep"},{"key":"10.1016\/j.mib.2024.102454_bib44","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s11427-022-2168-8","article-title":"Structural characterization of SARS-CoV-2 dimeric ORF9b reveals potential fold-switching trigger mechanism","volume":"66","author":"Jin","year":"2023","journal-title":"Sci China Life Sci"},{"key":"10.1016\/j.mib.2024.102454_bib45","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.str.2006.05.012","article-title":"The crystal structure of ORF-9b, a lipid binding protein from the SARS coronavirus","volume":"14","author":"Meier","year":"2006","journal-title":"Structure"},{"key":"10.1016\/j.mib.2024.102454_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108761","article-title":"SARS-CoV-2 ORF9b inhibits RIG-I-MAVS antiviral signaling by interrupting K63-linked ubiquitination of NEMO","volume":"34","author":"Wu","year":"2021","journal-title":"Cell Rep"},{"key":"10.1016\/j.mib.2024.102454_bib47","doi-asserted-by":"crossref","first-page":"5376","DOI":"10.1002\/jmv.27050","article-title":"SARS-CoV-2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG-I\/MDA-5-MAVS, TLR3-TRIF, and cGAS-STING signaling pathways","volume":"93","author":"Han","year":"2021","journal-title":"J Med Virol"},{"key":"10.1016\/j.mib.2024.102454_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22179233","article-title":"Phosphorylation of SARS-CoV-2 Orf9b regulates its targeting to two binding sites in TOM70 and recruitment of Hsp90","volume":"22","author":"Brandherm","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.mib.2024.102454_bib49","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/s41423-020-0514-8","article-title":"SARS-CoV-2 Orf9b suppresses type I interferon responses by targeting TOM70","volume":"17","author":"Jiang","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.mib.2024.102454_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.700926","article-title":"RIG-I-like receptor-mediated recognition of viral genomic RNA of severe acute respiratory syndrome coronavirus-2 and viral escape from the host innate immune responses","volume":"12","author":"Kouwaki","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.mib.2024.102454_bib51","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/cr.2010.103","article-title":"Tom70 mediates activation of interferon regulatory factor 3 on mitochondria","volume":"20","author":"Liu","year":"2010","journal-title":"Cell Res"},{"key":"10.1016\/j.mib.2024.102454_bib52","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-23118-8","article-title":"Crystal structure of SARS-CoV-2 Orf9b in complex with human TOM70 suggests unusual virus-host interactions","volume":"12","author":"Gao","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.mib.2024.102454_bib53","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.02476-23","article-title":"Contrasting roles of MERS-CoV and SARS-CoV-2 internal proteins in pathogenesis in mice","author":"Wong","year":"2023","journal-title":"mBio"},{"key":"10.1016\/j.mib.2024.102454_bib54","article-title":"Evolutionary arms race between SARS-CoV-2 and interferon signaling via dynamic interaction with autophagy","author":"Lee","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.mib.2024.102454_sbref55","doi-asserted-by":"crossref","DOI":"10.1093\/molbev\/msad142","article-title":"A noncoding A-to-U Kozak site change related to the high transmissibility of Alpha, Delta, and Omicron VOCs","volume":"40","author":"Yang","year":"2023","journal-title":"Mol Biol Evol"}],"container-title":["Current Opinion in Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1369527424000304?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1369527424000304?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T17:12:25Z","timestamp":1778605945000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1369527424000304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":55,"alternative-id":["S1369527424000304"],"URL":"https:\/\/doi.org\/10.1016\/j.mib.2024.102454","relation":{},"ISSN":["1369-5274"],"issn-type":[{"value":"1369-5274","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Upping the ante: enhanced expression of interferon-antagonizing ORF6 and ORF9b proteins by SARS-CoV-2 variants of concern","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Microbiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mib.2024.102454","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102454"}}